DrugsNews.net

Drugs Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Farmaexplorer.it

Search results for "Lorlatinib"

The European Commission ( EC ) has granted conditional marketing authorization for Lorviqua ( Lorlatinib, available in the U.S., Canada and Japan under the brand name Lorbrena ), as a monotherapy for ...